Min Hyung Jung

Min Hyung Jung

Auto-generated profile, based on publicly available information

Min Hyung Jung

School of Medicine, Kyung Hee University, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in The Tohoku Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MCMin-Hyung Chung
Min-Hyung Chung
CHChu-Yeop Huh
Chu-Yeop Huh
To evaluate the efficacy of various treatments for pelvic congestion syndrome in patients with different stress levels, we analyzed one hundred six patients with pelvic congestion syndrome, confirmed with laparoscopy and venography, who did not respond to medication after 4-6 months medication. They were divided into three groups: (embolotherapy; hysterectomy with bilateral oophorectomy and hormone replacement therapy; and hysterectomy with unilateral oophorectomy). The visual analog scale was used to measure degree of pain; stress level data were scored with the revised social readjustment rating scale. Embolotherapy was significantly more effective at reducing pelvic pain, compared to the other methods (p<0.05). The mean percentage decrease in pain was significantly greater in the patients with lower stress scores (p<0.05). Ovarian and/or internal iliac vein embolization appears to be a safe, well-tolerated, effective treatment for pelvic congestion syndrome that has not responded to medication.

16 April 2014 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
Ihn HanIhn Han
Ihn Han
MYMiyong Yun
Miyong Yun
EKEun-Ok Kim
Eun-Ok Kim
Bonglee KimBonglee Kim
Bonglee Kim
MJMin-Hyung Jung
Min-Hyung Jung
Sung-Hoon KimSung-Hoon Kim
Sung-Hoon Kim
Introduction: Although mesenchymal stem cells (MSCs) have antitumor potential in hepatocellular carcinoma and breast cancer cells, the antitumor mechanism of human umbilical cord mesenchymal stem cells (hUCMSCs) in prostate cancer cells still remains unclear. Thus, in the present study, we elucidated the antitumor activity of hUCMSCs in PC-3 prostate cancer cells in vitro and in vivo. Methods: hUCMSCs were isolated from Wharton jelly of umbilical cord and characterized via induction of differentiations, osteogenesis, and adipogenesis. Antitumor effects of UCMSCs on tumor growth were evaluated in a co-culture condition with PC-3 prostate cancer cells. PC-3 cells were subcutaneously (sc) injected into the left flank of nude mice, and UCMSCs were sc injected into the right flank of the same mouse. Results: We found that hUCMSCs inhibited the proliferation of PC-3 cells in the co-culture condition. Furthermore, co-culture of hUCMSCs induced the cleavage of caspase 9/3 and PARP, activated c-jun NH2-terminal kinase (JNK), and Bax, and attenuated the phosphorylation of phosphatidylinositol 3-kinase (PI3K)/ AKT, extracellular signal-regulated kinase (ERK), and the expression of survival genes such as Bcl-2, Bcl-xL, Survivin, Mcl-1, and cIAP-1 in PC-3 cells in Western blotting assay. Conversely, we found that treatment of specific JNK inhibitor SP600125 suppressed the cleavages of caspase 9/3 and PARP induced by hUCMSCs in PC-3 cells by Western blotting and immunofluorescence assay. The homing of hUCMSCs to, and TUNEL-positive cells on, the K562 xenograft tumor region were detected in Nu/nu-BALB/c mouse. Conclusions: These results suggest that UCMSCs inhibit tumor growth and have the antitumor potential for PC-3 prostate cancer treatment.

5 June 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YKYoung-Sun Kim
Young-Sun Kim
KKKyung Sook Kim
Kyung Sook Kim
Ihn HanIhn Han
Ihn Han
MKMi-Hyun Kim
Mi-Hyun Kim
MJMin Hyung Jung
Min Hyung Jung
HPHun-Kuk Park
Hun-Kuk Park
The antifungal activity of allicin and its synergistic effects with the antifungal agents flucytosine and amphotericin B (AmB) were investigated in Candida albicans (C. albicans). C. albicans was treated with different conditions of compounds alone and in combination (allicin, AmB, flucytosine, allicin + AmB, allicin + flucytosine, allicin + AmB + flucytosine). After a 24-hour treatment, cells were examined by scanning electron microscopy (SEM) and atomic force microscopy (AFM) to measure morphological and biophysical properties associated with cell death. The clearing assay was conducted to confirm the effects of allicin. The viability of C. albicans treated by allicin alone or with one antifungal drug (AmB, flucytosine) in addition was more than 40% after a 24-hr treatment, but the viability of groups treated with combinations of more than two drugs was less than 32%. When the cells were treated with allicin alone or one type of drug, the morphology of the cells did not change noticeably, but when cells were treated with combinations of drugs, there were noticeable morphological changes. In particular, cells treated with allicin + AmB had significant membrane damage (burst or collapsed membranes). Classification of cells according to their cell death phase (CDP) allowed us to determine the relationship between cell viability and treatment conditions in detail. The adhesive force was decreased by the treatment in all groups compare to the control. Cells treated with AmB + allicin had a greater adhesive force than cells treated with AmB alone because of the secretion of molecules due to collapsed membranes. All cells treated with allicin or drugs were softer than the control cells. These results suggest that allicin can reduce MIC of AmB while keeping the same efficacy.

9 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KKKyung Sook Kim
Kyung Sook Kim
YKYoung-Sun Kim
Young-Sun Kim
Ihn HanIhn Han
Ihn Han
MKMi-Hyun Kim
Mi-Hyun Kim
MJMin Hyung Jung
Min Hyung Jung
HPHun-Kuk Park
Hun-Kuk Park
The death process of Candida albicans was investigated after treatment with the antifungal agents flucytosine and amphotericin B by assessing morphological and biophysical properties associated with cell death. C. albicans was treated varying time periods (from 6 to 48 hours) and examined by scanning electron microscopy (SEM) and atomic force microscopy (AFM). SEM and AFM images clearly showed changes in morphology and biophysical properties. After drug treatment, the membrane of C. albicans was perforated, deformed, and shrunken. Compared to the control, C. albicans treated with flucytosine was softer and initially showed a greater adhesive force. Conversely, C. albicans treated with amphotericin B was harder and had a lower adhesive force. In both cases, the surface roughness increased as the treatment time increased. The relationships between morphological changes and the drugs were observed by AFM clearly; the surface of C. albicans treated with flucytosine underwent membrane collapse, expansion of holes, and shrinkage, while the membranes of cells treated with amphotericin B peeled off. According to these observations, the death process of C. albicans was divided into 4 phases, CDP0, CDP1, CDP2, and CDP4, which were determined based on morphological changes. Our results could be employed to further investigate the antifungal activity of compounds derived from natural sources.

19 July 2022 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
JKJu Hee Kim
Ju Hee Kim
MJMin Hyung Jung
Min Hyung Jung
SHSe Hwa Hong
Se Hwa Hong
MOON NALAEMOON NALAE
MOON NALAE
DKDae Ryong Kang
Dae Ryong Kang
Kim JH, et al. Yonsei Med J. 2022 Aug;63(8):794-798. https://doi.org/10.3349/ymj.2022.63.8.794

30 November 2010 in Proteomics
Verified
Journal Article
Closed access
PDF file
Ihn HanIhn Han
Ihn Han
SJSoo-Jin Jeong
Soo-Jin Jeong
HLHyo-Jung Lee
Hyo-Jung Lee
WKWonil Koh
Wonil Koh
HLHyo-Jeong Lee
Hyo-Jeong Lee
Sung-Hoon KimSung-Hoon Kim
Sung-Hoon Kim